Developmentally induced imbalance of dopaminergic fibre densities in limbic brain regions of gerbils (Meriones unguiculatus) A. BuscheD. PolascheckG. Teuchert-Noodt OriginalPaper 17 February 2004 Pages: 451 - 463
Adenosine A1 receptor distribution in the nucleus tractus solitarii of normotensive and spontaneously hypertensive rats D. C. CarrettieroD. R. Fior-Chadi OriginalPaper 04 February 2004 Pages: 465 - 473
Platelet monoamine oxidase activity in subjects tested for Huntington’s disease gene mutation M. MarkianosM. PanasD. Vassilopoulos OriginalPaper 04 February 2004 Pages: 475 - 483
A quantitative study of the pathological changes in ten patients with multiple system atrophy (MSA) R. A. ArmstrongN. J. CairnsP. L. Lantos OriginalPaper 17 February 2004 Pages: 485 - 495
Pharmacological and PET studies in patient’s with Parkinson’s disease and a short duration-motor response: implications in the pathophysiology of motor complications G. LinazasoroA. AntoniniK.-L. Leenders OriginalPaper 04 February 2004 Pages: 497 - 509
The outcome of patients with severe head injuries treated with amantadine sulphate B. SaniovaM. DrobnyM. Minarik Short Communication 17 February 2004 Pages: 511 - 514
Screening for mutations of the IRP2 gene in Parkinson’s disease patients with hyperechogenicity of the substantia nigra J. DeplazesK. SchöbelD. Berg Short Communication Pages: 515 - 521
Experimental traumatic brain injury in rats stimulates the expression, production and activity of Alzheimer’s disease β-secretase (BACE-1) I. BlaskoR. BeerR. Schliebs OriginalPaper 04 February 2004 Pages: 523 - 536
Transcription factor AP-2β genotype, striatal dopamine D2 receptor density and cerebrospinal fluid monoamine metabolite concentrations in humans M. DambergC. BerggårdE. G. Jönsson OriginalPaper 31 December 2003 Pages: 537 - 545
Elevated S-adenosylhomocysteine in Alzheimer brain: influence on methyltransferases and cognitive function B. P. KennedyT. BottiglieriE. Masliah OriginalPaper 04 February 2004 Pages: 547 - 567